NCT03971110 A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy. Status TERMINATED Phase PHASE4
NCT03936218 Goserelin 10.8mg Injection in Treatment of Advanced Prostate Cancer Status COMPLETED Phase PHASE3
NCT03651271 Nivolumab With or Without Ipilimumab in Advanced Metastatic Cancer Status COMPLETED Phase PHASE2
NCT03577028 Study of HPN424 in Patients With Advanced Prostate Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT03511196 Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT02925702 PRORADIUM: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Radium-223. Status UNKNOWN Phase N/A
NCT02922218 PROSENZA: Prospective Multi-Centre Study of Prognostic Factors in mCRPC Patients Treated With Enzalutamide. Status UNKNOWN Phase N/A
NCT02787837 PROSABI: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Abiraterone Acetate. Status UNKNOWN Phase N/A
NCT02420977 Evaluation of PSMA-based PET as an Imaging Biomarker in Prostate Cancer Status COMPLETED Phase EARLY_PHASE1
NCT02362620 PROSTAC: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Docetaxel or Cabazitaxel. Status UNKNOWN Phase N/A
NCT02234089 Therapy Pathways in the Treatment of Hormone Naïve Prostate Cancer Patients With and Without Comorbidities Treated With Degarelix or Luteinizing-Hormone-Releasing-Hormone (LHRH) Agonists. Status COMPLETED Phase N/A
NCT02035124 Cabazitaxel and BKM120 in Patients With Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel Status WITHDRAWN Phase PHASE2
NCT01383863 A Long-term Observational Study Cohort in Patients With Advanced Prostate Cancer Status COMPLETED Phase N/A
NCT01306890 A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer Status COMPLETED Phase N/A
NCT01224405 Prostate Cancer, Androgen Deprivation Withdrawal and Intermittent Chemotherapy Status UNKNOWN Phase PHASE3
NCT01078545 Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS) Status COMPLETED Phase N/A
NCT00871585 Evaluation of Prostate-Specific Antigen (PSA) Levels in Patients With Advanced Prostate Cancer Treated With Bicalutamide Status COMPLETED Phase N/A